Cargando…
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
BACKGROUND: Few data are available on compliance and safety of adjuvant chemotherapy when indicated in elderly breast cancer patients; CMF (cyclophosphamide, methotrexate, fluorouracil) can be reasonably considered the most widely accepted standard of treatment. METHODS: We retrospectively reviewed...
Autores principales: | De Maio, Ermelinda, Gravina, Adriano, Pacilio, Carmen, Amabile, Gerardo, Labonia, Vincenzo, Landi, Gabriella, Nuzzo, Francesco, Rossi, Emanuela, D'Aiuto, Giuseppe, Capasso, Immacolata, Rinaldo, Massimo, Morrica, Brunello, Elmo, Massimo, Di Maio, Massimo, Perrone, Francesco, de Matteis, Andrea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079800/ https://www.ncbi.nlm.nih.gov/pubmed/15790416 http://dx.doi.org/10.1186/1471-2407-5-30 |
Ejemplares similares
-
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial
por: Nuzzo, Francesco, et al.
Publicado: (2011) -
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
por: Pacilio, C, et al.
Publicado: (2006) -
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
por: De Maio, Ermelinda, et al.
Publicado: (2007) -
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
por: Gallo, Ciro, et al.
Publicado: (2006) -
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)